Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/20332457

Download in:

View as

General Info

PMID
20332457